Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| FEDERAL MOGU | FDML | 8.53% |
| SCIENTIFIC L | SCIL | 8.00% |
| RADIANT LOGI | RLGT | 6.38% |
| SUMMER INFAN | SUMR | 5.42% |
| NATUS MEDICA | BABY | 5.41% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Buckle Inc. ( BKE - Snapshot Report ) reported net sales of $94.9 million in November 2011, up 9.2% from $86.9 million in the comparable month last year. The company’s comparable store sales rose 6.9% in the same period.
Total sales for the men’s side of business increased 11.0% year over year and represented 40.0% of total sales for the month, flat year over year. Sales from the women’s side of business accounted for 60.0% of total sales, reflecting an 8.5% increase. In the year-earlier month also, women’s segment accounted for the same percentage.
Pricing in the women's side of the business was steadier compared to men’s. Overall pricing was up 9.5% in the women’s side of business while the men’s side saw an 8.5% increment. This was a trend reversal as men’s side was a stronger performer during the last few months. Average accessory price points were up about 3%, but average footwear price points were up approximately 6.0% for the month. Black Friday store promotions were comparatively lesser than many of its mall-based peers.
In November, the categories that performed well were denim, woven and knit tops, sweaters, outerwear, accessories and footwear. Accessory sales for men's and women's categories together declined approximately 2.5% in comparison to the prior-year month while footwear business grew approximately 13.0%.
Buckle ended November with 431 retail stores in 43 states compared with 422 stores in 41 states as of December 1, 2010. For fiscal 2011, the company opened 13 new stores. Additionally, the company anticipates completing 25 remodels in fiscal 2011.
The Zacks Consensus earnings estimates for the fourth quarter and fiscal 2011 are pegged at $1.11 and $3.13, respectively. Following the solid monthly results, an optimistic outlook prevails around the stock. Of the nine analysts covering the stock, two raised their estimates both for the upcoming quarter and fiscal year to reflect the company’s fundamental strength.
Buckle, which mainly caters to older teens and young adults, currently retains a Zacks #2 Rank that translates into a short-term Buy rating. We are also maintaining our long-term Neutral recommendation on the stock. One of its competitors, Cato Corp. ( CATO ) reported a 3.0% downside in total sales and a 5.0% decrease in same-store sales in November.
Read the full Snapshot Report on BKE
Read the full on CATO